RDN-2150 | Interleukin Related interleukin-related.com

Product Name :
RDN-2150

Search keywords :
RDN2150

drugId :
null

Target Vo:
Tyrosine-protein kinase ZAP-70

Target Vo Short Name :
ZAP70

Moa_Name:
Tyrosine-protein kinase ZAP-70 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Shanghai Institute Of Materia Medica, Chinese Academy Of Sciences

Active Company_Name :
Shanghai Institute Of Materia Medica, Chinese Academy Of Sciences

Active Indication_Name:
Psoriasis

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Preclinical

China Highest Status:
Preclinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Cdk5 Rabbit mAb site
EpCAM Mouse mAb MedChemExpress
Annexin A2 Antibody: Annexin A2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 39 kDa, targeting to Annexin A2. It can be used for WB,IHC-P,ICC/IF,FC assays with tag free, in the background of Human, Mouse.

Author: Interleukin Related

Related Posts